期刊文献+

胃肝样腺癌9例报道及文献复习

Hepatoid adenocarcinoma of stomach: clinical and pathologic analysis and review of literature
原文传递
导出
摘要 目的 :探讨胃肝样腺癌(adenocarcinoma of stomach,HAS)患者的临床病理特征,以提高医师对该病的认识及诊断水平。方法:分析9例HAS患者的临床表现、病理形态特征及免疫组织化学检测结果,并结合文献进行探讨。结果:9例HAS患者中,8例为男性,1例女性;平均为(64±10)岁,临床主要表现为上腹部隐痛、黑便或进餐时呕吐。8例患者术前行血清甲胎蛋白(α-fetoprotein,AFP)检测,其中6例升高。病理检查结果显示,HAS在组织形态学上具有肝细胞癌的分化特征,而免疫组织化学检测显示存在不同程度的AFP表达。结论:HAS罕见,且易发生淋巴结及肝脏转移,及早诊断有助于改善患者的临床预后。 Objective: To study the clinicopathologic characteristics of hepatoid adenocarcinoma(HAS) of stomach for improving the recognition and diagnosis of HAS. Methods: A total of 9 patients with HAS of stomach were enrolled. Clinical symptoms, pathological characteristics and immunohistochemical staining of lesions were analyzed and relevant literatures were reviewed. Result: Of these 9 patients, the mean age was(64±10) years, and 8 patients were male. Serum AFP was increased in 6 cases. The major clinical manifestations were abdominal pain, melena or vomiting. Pathological examination revealed that HAS had histological differentiation characteristics of hepatocellular carcinoma. The tumor cells were immunohistochemially positive for AFP in various degree. Conclusions: HAS is a rare tumor which is prone to lymph node and liver metastases. Early detection and differentiation of HAS by histopathology may improve the clinical prognosis.
出处 《诊断学理论与实践》 2015年第5期429-432,共4页 Journal of Diagnostics Concepts & Practice
关键词 胃肝样腺癌 甲胎蛋白 临床病理 免疫组织化学 Hepatoid adenocarcinoma of stomach Alpha-fetoprotein Clinicopathology Immunohistochemistry
  • 相关文献

参考文献14

  • 1Metzgeroth G, Strbel P, Baumbusch T, et al. Hepatoid adenocarcinoma-review of the literature illustrated by a rare case originating in the peritoneal cavity[J]. Onkologie, 2010,33 (5):263 -269.
  • 2Bourreille J, Metayer P, Sauger F, et al. Existence of al- pha feto protein during gastric-origin secondary cancer of the liver[J]. Presse Med,1970,78(28):1277-1278.
  • 3Ishikura H, Kishimoto T, Andachi H, et al. Gastrointesti-nal hepatoid adenocarcinoma: venous permeation and mimicry of hepatocellular carcinoma, a report of four ca- ses[J]. Histopathology,1997,31 (1):47-54.
  • 4Nagai E, Ueyama T, Yao T, et al. Hepatoid adenocarci- noma of the stomach. A clinicopathologic and immuno- histochemical analysis[J]. Cancer,1993,72(6):1827-1835.
  • 5Kodama T, Kameya T, Hirota T, et al. Production of al- pha-fetoprotein, normal serum proteins, and human chorionic gonadotropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases[J]. Cancer,1981, 48(7):1647-1655.
  • 6Kumashiro Y, Yao T, Aishima S, et al. Hepatoid adeno- carcinoma of the stomach: histogenesis and progression in association with intestinal phenotype[J]. Hum Pathol,2007, 38(6):857-863.
  • 7Hishinuma M, Ohashi KI, Yamauchi N, et al. Hepatocel- lular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma[J]. Histo- lpathoogy,2006,49(5):479-486.
  • 8Luo HF, Wang HJ, Tan G, et al. Hepatoid adenocarcino- ma in stomach: a case report[J]. Chinese-German J Clin Oncol,2011,1 (10):297-299.
  • 9Grlvez-Mufioz E, Gallego-Plazas J, Gonzalez-Orozco V, et al. Hepatoid adenocarcinoma of the stomach-a different histology for not so different gastric adenocarcinoma: a case report[J]. Int Semin Surg Oncol,2009,6:13.
  • 10Baek SK, Han SW, Oh DY, et al. Clinicopathologie cha- racteristics and treatment outcomes of hepatoid adenocar- cinoma of the stomach, a rare but unique subtype of gas- tric cancer[J]. BMC Gastroenterol,2011,11:56.

二级参考文献26

  • 1Bourreille J,Metayer P,Sauger F,et al.Existence of alpha feto protein during gastric-origin secondary cancer of the liver[J].Presse Med,1970,78(28):1277-1278.
  • 2Ishikura H,Fukasawa Y,Ogasawara K,et al.An AFPproducing gastric carcinoma with features of hepatic differentiation.A case report[J].Cancer,1985,56 (4):840-848.
  • 3lnagawa S,Shimazaki J,Hori M,et al.Hepatoid adenocarcinoma of the stomach[J].Gastric Cancer,2001,4(1):43-52.
  • 4Morimoto H,Tanigawa N,lnoue H,et al.Alpha-fetoprotein-producing renal cell carcinoma[J].Cancer,1988,61(1):84-88.
  • 5Fujii H,Ichikawa K,Takagaki T,et al.Genetic evolution of alpha fetoprotein producing gastric cancer[J].J Clin Pathol,2003,56(l 2):942-949.
  • 6Tsukamoto T,Mizoshita T,Tatematsu M.Gastric-and-intestinal mixed-type intestinal metaplasia:aberrant expression of transcription factors and stem cell intestinalization[J].Gastric Cancer,2006,9(3):156-166.
  • 7Hamilton SR,Aaltonen LA.World Health Organization classification of tumours-pathology and genetics:tumours of digestive system[M].Lyon:Iarc Press,2000:45.
  • 8Antonini C,Forgiarini O,Chiara A,et al.Hepatoid adenocareinoma of the stomach.Case report and review of the literature[J].Pathologica,1997,89(3):310-316.
  • 9Morinaga S,Takahashi Y.Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis:an unusual association[J].Jpn J Clin Oncol,1996,26(4):258-263.
  • 10Nagai E,Ueyama T,Yao T,et al.Hepatoid adenocarcinoma of the stomach.A clinicopathologic and immunohistochemical analysis[J].Cancer,1993,72(6):1827-1835.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部